Morphic Therapeutic

Morphic Therapeutic is a biopharmaceutical company developing a pipeline of oral integrin therapies to treat serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. Morphic is advancing its pipeline and discovery activities using its proprietary MInT technology platform, which leverages the company’s unique understanding of integrin structure and biology.